Shopping Cart
- Remove All
- Your shopping cart is currently empty
Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2), in development for treating type 2 diabetes mellitus (T2DM). It inhibits SGLT2, responsible for at least 90% of glucose reabsorption in the kidney.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $37 | In Stock | |
25 mg | $44 | In Stock | |
50 mg | $56 | In Stock | |
100 mg | $70 | In Stock | |
500 mg | $170 | In Stock | |
1 mL x 10 mM (in DMSO) | $30 | In Stock |
Description | Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2), in development for treating type 2 diabetes mellitus (T2DM). It inhibits SGLT2, responsible for at least 90% of glucose reabsorption in the kidney. |
Targets&IC50 | SGLT2: |
In vitro | Dapagliflozin (2S)-1,2-propanediol, hydrate is the S-enantiomer of Dapagliflozin 1,2-propanediol, hydrate. Dapagliflozin inhibits sodium/glucose cotransporter 2 (SGLT2), which results in excretion of glucose into the urine. |
Alias | Dapagliflozin propanediol monohydrate, BMS-512148 (2S)-1,2-propanediol, hydrate |
Molecular Weight | 502.98 |
Formula | C24H35ClO9 |
Cas No. | 960404-48-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (99.41 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.